One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-137603
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
Affiliation: University of Lübeck, University of Brescia, Ospedale Niguarda Ca' Granda, University Hospital Carl Gustav Carus, Rambam Health Care Campus, Leitat Technological Center, Novartis (India), Novartis (Switzerland), Tris Pharma (United States), Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, Centre Hospitalier Universitaire de Grenoble, Seoul National University Hospital, Hôpital Cardiologique du Haut-Lévêque, Universität Hamburg, University Medical Center Hamburg-Eppendorf, Royal Brisbane and Women's Hospital, Ankara University, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Centre Hospitalier Universitaire de Nancy, Inserm, Université Paris CitéSafety Analysis of Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients (pts) with Steroid-Refractory (SR) Acute Graft-Vs-Host Disease (aGVHD) in the Randomized Phase 3 REACH2 Study
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
